In future work, it will be important to investigate the molecular features that distinguish p16Ink4a -expressing β-cells from p21Cip1-expressing β-cells in the context of T1D and T2D mouse models and human islets. This evidence concerns the gene CDKN2A and type 1 diabetes mellitus.